- January 25, 2025
- Posted by: admin
- Category: Uncategorized
No Comments
The MICROB-PREDICT General Assembly was held on January 27-29, 2025. Partners discussed the latest results and project updates. Together partners also celebrated exciting progress in the clinical study: MICROB-PREDICT’s ALB-TRIAL has hit a significant milestone in January, with 25% of the targeted 240 patients enrolled across nine active centres in Europe, with more sites joining soon! More on IP-cureB here. https://microb-predict.eu/